| Net Cash Provided by (Used in) Operating Activities |
-24M |
USD |
-168% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
14.7M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
9.8M |
shares |
-5.03% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-9.35M |
USD |
-177% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
9.98M |
USD |
-77.4% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
5.27M |
USD |
-4.04% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
800K |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
800K |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
17.2M |
USD |
-21.3% |
Q3 2025 |
Q3 2025 |